Cargando…

Treatment and Response Evaluation Challenges in a Pregnant Woman With B-Cell Lymphoblastic Leukemia and Li-Fraumeni Syndrome

Li-Fraumeni syndrome (LFS) is a cancer predisposing syndrome caused by pathogenic germline TP53 gene mutations with important therapeutic and prognostic implications for many types of cancer. A small proportion of LFS patients develop B-cell lymphoblastic leukemia (B-ALL) in adult years. Standard tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erikstein, Bjarte Skoe, Ahmed, Aymen Bushra, Forthun, Rakel Brendsdal, Leh, Friedemann, Gjertsen, Bjørn Tore, Reikvam, Håkon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181328/ https://www.ncbi.nlm.nih.gov/pubmed/37187497 http://dx.doi.org/10.14740/jh1107

Ejemplares similares

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
por: Reikvam, Håkon, et al.
Publicado: (2017)

Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine
por: Bredholt, Therese, et al.
Publicado: (2013)

Clinical proteomics of myeloid leukemia
por: Hjelle, Sigrun M, et al.
Publicado: (2010)

Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2012)

Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype
por: Reikvam, Håkon, et al.
Publicado: (2019)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis
por: Brattås, Marte Karen, et al.
Publicado: (2018)

Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome
por: Winter, Greta, et al.
Publicado: (2021)

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System
por: Nordgård, Oddmund, et al.
Publicado: (2021)

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)

Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)

Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
por: Pantziarka, Pan, et al.
Publicado: (2022)

A Case of Li-Fraumeni Associated Thymoma
por: Sivayoganathan, Thibacg, et al.
Publicado: (2022)

Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia
por: Andresen, Vibeke, et al.
Publicado: (2016)

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation
por: Hemsing, Anette Lodvir, et al.
Publicado: (2021)

Immunoglobulin-Storing Histiocytosis: A Case Based Systemic Review
por: Wiese-Hansen, Hanne, et al.
Publicado: (2021)

Li-Fraumeni syndrome--a molecular and clinical review.
por: Varley, J. M., et al.
Publicado: (1997)

Li-Fraumeni Syndrome: A Rare Genetic Disorder
por: Tazin, Faria, et al.
Publicado: (2022)

Li‐Fraumeni versus Pseudo‐Li‐Fraumeni Syndrome: Key Insights for Interpreting Next‐Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes
por: Sorscher, Steven, et al.
Publicado: (2017)

Li-Fraumeni syndrome: a case report from Italy.
por: Orjuela, M., et al.
Publicado: (1990)

Li Fraumeni syndrome, cancer and senescence: a new hypothesis
por: Pantziarka, Pan
Publicado: (2013)

PEComa in a Young Patient with Known Li-Fraumeni Syndrome
por: Neofytou, Kyriakos, et al.
Publicado: (2015)

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
por: Pantziarka, Pan
Publicado: (2015)

Prostate Cancer and Li-Fraumeni Syndrome: Implications for Screening and Therapy
por: Spees, Colleen K., et al.
Publicado: (2015)

The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome
por: Yoshida, Tsukasa, et al.
Publicado: (2017)

CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome
por: Chen, Liting, et al.
Publicado: (2020)

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
por: Tjensvoll, Kjersti, et al.
Publicado: (2022)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
por: Lammens, C. R. M., et al.
Publicado: (2010)

Genetic and functional analysis of a Li Fraumeni syndrome family in China
por: Hu, Huaying, et al.
Publicado: (2016)

Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives
por: Kumar, Prerna, et al.
Publicado: (2018)

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Difficulties of Management of Multiple Synchronous Bone Tumors in Li-Fraumeni Syndrome
por: Huby, Marine, et al.
Publicado: (2019)

Maxillary mesenchymal chondrosarcoma leading to a diagnosis of Li-Fraumeni syndrome
por: Ventura, Eduardo, et al.
Publicado: (2020)

Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
por: Li, Jiabing, et al.
Publicado: (2023)

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
por: Reikvam, Håkon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9304ot0192cp3natinff919ucj